News: OTIC Announces FDA Approval of OTIPRIO(R) for Acute Otitis Externa
Time: Friday, March 02, 2018 12:15
Intraday Maximum Change: $-0.475 - -8.52% Minutes After: 168
Latest Quote: 4.525 Change Since: $-1.525 - -33.7% Days Since: 81
Snapshot of company's key stats at the time of the event
Market Cap: 165,337,299 Shares Outstanding: 30,337,119 Float: 30,294,157
Day's Short Interest: 1,005,731 Short Ratio: 2.94%
Institutional Ownership: 32.9% Insider Ownership: 0%
OTIC - Otonomy Inc.
Sector: Healthcare - Industry: Biotechnology
Otonomy Inc is a biopharmaceutical company, focuses on the development and commercialization of therapeutics for diseases and disorders of the ear.